FTIWX
Price
$14.83
Change
-$0.04 (-0.27%)
Updated
Aug 20 closing price
Net Assets
6.27B
RBBCX
Price
$12.75
Change
+$0.01 (+0.08%)
Updated
Aug 21 closing price
Net Assets
826.08M
Interact to see
Advertisement

FTIWX vs RBBCX

FTIWX vs RBBCX Comparison Chart in %
View a ticker or compare two or three
VS
FTIWX vs. RBBCX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTIWX is a StrongBuy and RBBCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTIWX has more cash in the bank: 6.27B vs. RBBCX (826M). RBBCX pays higher dividends than FTIWX: RBBCX (3.18) vs FTIWX (2.98). FTIWX was incepted earlier than RBBCX: FTIWX (20 years) vs RBBCX (21 years). RBBCX (1.71) is less costly to investors than FTIWX (0.53). FTIWX is a more actively managed with annual turnover of: 31.00 vs. RBBCX (12.00). FTIWX has a lower initial minimum investment than RBBCX: FTIWX (0) vs RBBCX (2000). RBBCX IRA initial investment is lower compared to FTIWX: RBBCX (1000) vs FTIWX (500). RBBCX (8.73) and FTIWX (8.60) have marching annual gain over last year. FTIWX return over 5 years is better than : 15.35 vs. RBBCX (10.67).
FTIWXRBBCXFTIWX / RBBCX
Total Expense Ratio0.511.7130%
Annual Report Gross Expense Ratio0.531.7131%
Fund Existence20 years21 years-
Gain YTD4.6784.699100%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRA500100050%
Net Assets6.27B826M759%
Annual Yield % from dividends2.983.1894%
Returns for 1 year8.608.7399%
Returns for 3 years27.2429.2193%
Returns for 5 years15.3510.67144%
Returns for 10 years38.3041.9491%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNTH111.101.59
+1.45%
Dianthus Therapeutics
GSIW17.020.22
+1.31%
Garden Stage Limited
SYK329.451.75
+0.53%
Stryker Corp
LCTX1.08N/A
N/A
Lineage Cell Therapeutics
MLTX15.76-0.11
-0.69%
MoonLake Immunotherapeutics